Results 11 to 20 of about 4,293,758 (238)

Cost–consequence analysis of 18F-fluciclovine for the staging of recurrent prostate cancer

open access: yesJournal of Market Access & Health Policy, 2020
Background: Current detection methodologies are often unable to identify the location and extent of recurrent prostate cancer (PCa) leading potentially to ‘futile’ local therapies in the presence of metastatic disease. The use of 18 F-fluciclovine PET/CT
Ivar S Jensen   +4 more
doaj   +2 more sources

Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia

open access: yesClinicoEconomics and Outcomes Research, 2018
Gabriel Tremblay,1 Mike Dolph,1 Menaka Bhor,2 Qayyim Said,2 Brian Elliott,2 Andrew Briggs3 1Department of Health Economics, Purple Squirrel Economics, New York, NY, USA; 2Department of Health Economics and Outcomes Research, Novartis Pharmaceuticals ...
Tremblay G   +5 more
doaj   +1 more source

Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia

open access: yesClinicoEconomics and Outcomes Research, 2018
Gabriel Tremblay,1 Mike Dolph,1 Menaka Bhor,2 Qayyim Said,2 Anuja Roy,2 Brian Elliott,3 Andrew Briggs4 1Health Economics, Purple Squirrel Economics, New York, NY, USA; 2Health Economics and Outcomes Research, Novartis Pharmaceuticals, East 
Tremblay G   +6 more
doaj   +1 more source

Cost-consequence analysis of sitagliptin versus sulfonylureas as add-on therapy for the treatment of diabetic patients in Italy

open access: yesClinicoEconomics and Outcomes Research, 2017
Valentina Lorenzoni,1 Fabio Baccetti,2 Stefano Genovese,3 Enrico Torre,4 Giuseppe Turchetti1 1Institute of Management, Scuola Superiore Sant’Anna, Pisa, Italy; 2SD Diabetology, ASL Toscana Nordovest, Massa Carrara, Italy; 3Cardiovascular and ...
Lorenzoni V   +4 more
doaj   +1 more source

Evaluating stroke early supported discharge using cost-consequence analysis [PDF]

open access: yes, 2021
To evaluate different stroke early supported discharge (ESD) services in different geographical settings using cost-consequence analysis (CCA), which presents information about costs and outcomes in the form of a balance sheet. ESD is a multidisciplinary
Peter Langhorne (23534)   +8 more
core   +5 more sources

Cost–consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHS

open access: yesClinicoEconomics and Outcomes Research, 2018
Laura Amanda Vallejo-Aparicio,1 Germán Peces-Barba,2 Alicia Gil,3 Alicia Huerta Hernandez1 1Market Access, GlaxoSmithKline, Tres Cantos, Madrid, Spain; 2IIS-Fundación Jiménez Díaz.
Vallejo-Aparicio LA   +3 more
doaj   +1 more source

Cost and consequences of using 7.1 % chlorhexidine gel for newborn umbilical cord care in Kenya

open access: yesBMC Health Services Research, 2021
Background Omphalitis is an important contributor to neonatal mortality in Kenya. Chlorhexidine digluconate 7.1 % w/w (CHX; equivalent to 4 % w/w chlorhexidine) was identified as a life-saving commodity for newborn cord care by the United Nations and is ...
Lecia Brown   +6 more
doaj   +1 more source

Cost consequence analysis of waiting for lumbar disc herniation surgery

open access: yesScientific Reports, 2023
The economic repercussions of waiting for lumbar disc surgery have not been well studied. The primary goal of this study was to perform a cost-consequence analysis of patients receiving early vs late surgery for symptomatic disc herniation from a ...
Charlotte Dandurand   +22 more
doaj   +1 more source

Chemical Recovery of Degraded Soil and Consequence in the Cost of Corn Production [PDF]

open access: yesBrazilian Archives of Biology and Technology, 2020
Improper management degrades the soil, decreases corn productivity and is reflected in the cost of production. The objective of this research was to evaluate the soil recovery in non-conservationist treatments after the change of management and ...
Neuro Hilton Wolschick   +4 more
doaj   +1 more source

Amalgam versus composite restorations: a cost-consequence analysis. [PDF]

open access: yesBr Dent J
\ua9 The Author(s) 2026.Aims Amalgam is being phased out globally by 2034. Under English NHS provision, amalgam is predominantly used to restore posterior teeth. A broad evaluation of the comparative costs and consequences of using amalgam versus various
Bailey O   +3 more
europepmc   +4 more sources

Home - About - Disclaimer - Privacy